Thousands More Patients Will Soon Be Able to Use IBM's Watson to Fight Cancer

IBM ibm Watson is teaming up with Quest Diagnostics dgx in a significant expansion of its ongoing cancer genomic sequencing and precision medicine push. The company announced Monday it is launching a new service with lab testing giant Quest and New York's Memorial Sloan Kettering Cancer Center called Watson Genomics from Quest Diagnostics. "The service will make Watson for Genomics widely available to physician and patients nationwide for the first time," said IBM in a statement. IBM has already struck prominent collaborative arrangements with major cancer research centers like those at the Broad Institute of MIT and Harvard. The firm is trying to help oncologists identify the proper treatments and clinical trials for their patients' specific cancers.